In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells.
Ulivi P, Arienti C, Zoli W, Scarsella M, Carloni S, Fabbri F, Tesei A, Chiadini E, Orlandi A, Passeri D, Zupi G, Milandri C, Silvestrini R, Amadori D, Leonetti C.
Ulivi P, et al. Among authors: amadori d.
Curr Cancer Drug Targets. 2010 Sep;10(6):600-10. doi: 10.2174/156800910791859489.
Curr Cancer Drug Targets. 2010.
PMID: 20491617
Review.